BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15905175)

  • 1. G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor.
    Mifune M; Ohtsu H; Suzuki H; Nakashima H; Brailoiu E; Dun NJ; Frank GD; Inagami T; Higashiyama S; Thomas WG; Eckhart AD; Dempsey PJ; Eguchi S
    J Biol Chem; 2005 Jul; 280(28):26592-9. PubMed ID: 15905175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
    Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.
    Shah BH; Yesilkaya A; Olivares-Reyes JA; Chen HD; Hunyady L; Catt KJ
    Mol Endocrinol; 2004 Aug; 18(8):2035-48. PubMed ID: 15143154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide-induced transactivation of a neuronal epidermal growth factor receptor is mediated by metalloprotease-dependent formation of heparin-binding epidermal growth factor.
    Shah BH; Farshori MP; Catt KJ
    J Biol Chem; 2004 Jan; 279(1):414-20. PubMed ID: 14573593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells.
    Göőz M; Göőz P; Luttrell LM; Raymond JR
    J Biol Chem; 2006 Jul; 281(30):21004-21012. PubMed ID: 16737974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.
    Uchiyama-Tanaka Y; Matsubara H; Nozawa Y; Murasawa S; Mori Y; Kosaki A; Maruyama K; Masaki H; Shibasaki Y; Fujiyama S; Nose A; Iba O; Hasagawa T; Tateishi E; Higashiyama S; Iwasaka T
    Kidney Int; 2001 Dec; 60(6):2153-63. PubMed ID: 11737589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding.
    Yin J; Yu FS
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):132-9. PubMed ID: 18658095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process.
    Le Gall SM; Auger R; Dreux C; Mauduit P
    J Biol Chem; 2003 Nov; 278(46):45255-68. PubMed ID: 12947092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II.
    Ohtsu H; Dempsey PJ; Frank GD; Brailoiu E; Higuchi S; Suzuki H; Nakashima H; Eguchi K; Eguchi S
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):e133-7. PubMed ID: 16840716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors.
    Yan Y; Shirakabe K; Werb Z
    J Cell Biol; 2002 Jul; 158(2):221-6. PubMed ID: 12119356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct mechanisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-delta.
    Frank GD; Mifune M; Inagami T; Ohba M; Sasaki T; Higashiyama S; Dempsey PJ; Eguchi S
    Mol Cell Biol; 2003 Mar; 23(5):1581-9. PubMed ID: 12588978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
    Asakura M; Kitakaze M; Takashima S; Liao Y; Ishikura F; Yoshinaka T; Ohmoto H; Node K; Yoshino K; Ishiguro H; Asanuma H; Sanada S; Matsumura Y; Takeda H; Beppu S; Tada M; Hori M; Higashiyama S
    Nat Med; 2002 Jan; 8(1):35-40. PubMed ID: 11786904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding.
    Pierce KL; Tohgo A; Ahn S; Field ME; Luttrell LM; Lefkowitz RJ
    J Biol Chem; 2001 Jun; 276(25):23155-60. PubMed ID: 11290747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor in adipocytes in vitro.
    Yamamoto T; Suganami T; Kiso-Narita M; Scherle PA; Kamei Y; Isobe M; Higashiyama S; Ogawa Y
    Obesity (Silver Spring); 2010 Oct; 18(10):1888-94. PubMed ID: 20111015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
    Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
    Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme.
    Nishi E; Hiraoka Y; Yoshida K; Okawa K; Kita T
    J Biol Chem; 2006 Oct; 281(41):31164-72. PubMed ID: 16923819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading.
    Gechtman Z; Alonso JL; Raab G; Ingber DE; Klagsbrun M
    J Biol Chem; 1999 Oct; 274(40):28828-35. PubMed ID: 10497257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane A2 receptor-mediated epidermal growth factor receptor transactivation: involvement of PKC-delta and PKC-epsilon in the shedding of epidermal growth factor receptor ligands.
    Uchiyama K; Saito M; Sasaki M; Obara Y; Higashiyama S; Nakahata N
    Eur J Pharm Sci; 2009 Dec; 38(5):504-11. PubMed ID: 19804825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes.
    Flannery PJ; Spurney RF
    Nephron Exp Nephrol; 2006; 103(3):e109-18. PubMed ID: 16554661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.